Ondansetron.
Thavaraj
V
V
Department of Pediatrics, All India Institute of Medical Sciences, New Delhi.
Arya
L S
LS
D000284:Administration, Oral; D000328:Adult; D000932:Antiemetics / Q000494:pharmacology / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D007275:Injections, Intravenous; D009325:Nausea / Q000188:drug therapy* / Q000209:etiology; D017294:Ondansetron / Q000494:pharmacology / Q000627:therapeutic use; D011878:Radiotherapy / Q000009:adverse effects; D012307:Risk Factors; D014839:Vomiting / Q000188:drug therapy* / Q000209:etiology
D000932:Antiemetics; D017294:Ondansetron